Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - CAPITAL EXPENDITURES
Capital Expenditures HRTX - Heron Therapeutics, Inc.
-1.54 M
LAST VALUE
28.50%
2 YEAR CAGR
29.97%
5 YEAR CAGR
0.86%
10 YEAR CAGR